Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder [Phase 2, Phase 3]
A Phase 2/3 augmentation trial of levetiracetam for obsessive-compulsive disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders [Phase 2, Phase 3]
This document reports the results of cognitive-behavioral therapy for anxiety disorders in children with autism spectrum disorders across Ph…
-
FDA approval · 2013-03-13FDA Approved: FLUVOXAMINE MALEATE — Original Application (Endo USA, Inc.)
FDA approves the Original Application for fluvoxamine maleate from Endo USA, Inc. as a generic medication.
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder [Phase 4]
Phase 4 trial evaluating the effectiveness of sertraline in combination with cognitive-behavioral therapy for pediatric obsessive-compulsive…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder [Phase 3]
This Phase 3 trial compared two family-based therapies for Obsessive-Compulsive Disorder in young children and has completed. The study was …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder [Phase 2]
Phase 2 trial investigating N-Acetylcysteine augmentation in treatment-refractory obsessive-compulsive disorder has been terminated with res…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Electrical Stimulation of the Internal Capsule for Intractable Obsessive-compulsive Disorder (OCD) [Phase 2]
A Phase 2 study evaluating electrical stimulation of the internal capsule for treatment of intractable obsessive-compulsive disorder has com…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Treating Refractory Obsessive Compulsive Disorder With rTMS [NA]
A completed clinical trial evaluated repetitive transcranial magnetic stimulation (rTMS) for treatment-refractory obsessive-compulsive disor…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Treatment of Obsessive Compulsive Disorder in Children [Phase 3]
A Phase 3 clinical trial evaluating a treatment for obsessive-compulsive disorder in children has completed, with results posted in 2013.
-
FDA approval · 2013-02-01FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by ROERIG.
-
FDA label_change · 2013-02-01FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA supplemental approval for sertraline hydrochloride from Mylan to update labeling.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Predicting Medication Response in Obsessive Compulsive Disorder [NA]
A completed clinical trial investigated predictors of medication response in obsessive-compulsive disorder.
-
FDA approval · 2013-01-29FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, Inc., indicating approval of changes to th…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder [Phase 2]
Phase 2 study evaluating low-dose ondansetron as adjunctive therapy for adults with obsessive-compulsive disorder was terminated; the update…
-
FDA approval · 2013-01-09FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for fluvoxamine maleate submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2013-01-03FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2012-12-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for sertraline hydrochloride by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-12-18FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2012-11-30FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for fluvoxamine maleate filed by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder [Phase 2]
Phase 2 trial evaluating a combination of Naltrexone SR and Fluoxetine for obsessive-compulsive disorder was terminated.
-
CLINICAL_TRIALS research · 2012-11-08Clinical Trial Update: Differences in Cognitive Performance and Brain Activity Between Patients With PTSD and OCD
This clinical trial update reports differences in cognitive performance and brain activity between patients with post-traumatic stress disor…
-
FDA label_change · 2012-10-26FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for clomipramine hydrochloride handled by SpecGx LLC, indicating an approved modification related to…
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder [Phase 2]
Phase 2 trial evaluating D-Cycloserine as augmentation to therapy for pediatric obsessive-compulsive disorder has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Radiosurgical Treatment for Obsessive-compulsive Disorder [Phase 2]
Phase 2 trial of radiosurgical treatment for obsessive-compulsive disorder was terminated; no efficacy results are provided in this update.
-
FDA approval · 2012-10-01FDA Approved: FLUOXETINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original (ANDA) application for fluoxetine from Heritage Pharmaceuticals (d/b/a Avet), confirming a generic formulation of …